Summit Therapeutics

About:

Summit Therapeutics is a clinical-stage drug discovery and development company.

Website: https://www.summittxinc.com

Twitter/X: Summitplc

Top Investors: Wellcome Trust, Eurofarma, Biomedical Advanced Research and Development Authority (BARDA), CARB-X, Jeff Huber

Description:

Summit Therapeutics is a clinical-stage drug discovery and development company. The company's new mechanism antibiotics are designed to become the new standards of care for the benefit of patients and create value for payors and healthcare providers.

Total Funding Amount:

$1.29B

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Abingdon, Oxfordshire, United Kingdom

Founded Date:

2003-01-01

Contact Email:

info(AT)summitplc.com

Founders:

Dame Kay Davies

Number of Employees:

101-250

Last Funding Date:

2024-09-11

IPO Status:

Public

© 2025 bioDAO.ai